Trial no.:
|
PACTR201703002137406 |
Date of Approval:
|
24/03/2017 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Video Assisted Thoracoscopic Surgery (VATS) versus Conventional Thoracotomy For management of empyema |
Official scientific title |
Video Assisted Thoracoscopic Surgery (VATS) Versus Conventional Thoracotomy incision For management of empyema thoracis |
Brief summary describing the background
and objectives of the trial
|
Empyema in Greek means; pus presence in pleural cavity. The precursor of empyema is bacterial pneumonia and subsequent parapneumonic effusion. Most patients with empyema present with clinical manifestations of bacterial pneumonia including; fever, pleuritic chest pain, cough and dyspnea. Physical findings and presentations may vary depending on the organism and duration of illness. Chest radiography, ultrasonography (US), computerized topography (CT) and pleural fluid analysis are the most important investigations. Pleural fluid analysis is important to confirm an empyema rather simple pleural effusion by the glucose, lactate dehydrogenase (LDH), protein level and PH. The aim of treatment in patients with empyema is to save lives, eliminate empyema, re-expand the trapped lung, restore mobility of the chest wall and diaphragm, return of respiratory function to normal, prevent complications or chronicity and reduce the duration of hospital stay. The pursuit of this aim has led to development of multiple therapeutic options including; repeated thoracocentesis closed tube thoracostomy, image directed inta-pleural catheter drainage, intra-pleural fibrinolytic therapy, VATS decortication, mini thoracotomy and standard thoracotomy with decortication. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
empyema thoracis, VATS,Respiratory |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Devices |
Anticipated trial start date |
19/03/2017 |
Actual trial start date |
19/03/2017 |
Anticipated date of last follow up |
19/02/2018 |
Actual Last follow-up date |
26/02/2018 |
Anticipated target sample size (number of participants) |
58 |
Actual target sample size (number of participants) |
58 |
Recruitment status |
Completed |
Publication URL |
|
|